1. Home
  2. BPMC vs OLLI Comparison

BPMC vs OLLI Comparison

Compare BPMC & OLLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • OLLI
  • Stock Information
  • Founded
  • BPMC 2008
  • OLLI 1982
  • Country
  • BPMC United States
  • OLLI United States
  • Employees
  • BPMC N/A
  • OLLI N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • OLLI Department/Specialty Retail Stores
  • Sector
  • BPMC Health Care
  • OLLI Consumer Discretionary
  • Exchange
  • BPMC Nasdaq
  • OLLI Nasdaq
  • Market Cap
  • BPMC 5.8B
  • OLLI 6.6B
  • IPO Year
  • BPMC 2015
  • OLLI 2015
  • Fundamental
  • Price
  • BPMC $101.35
  • OLLI $111.45
  • Analyst Decision
  • BPMC Buy
  • OLLI Buy
  • Analyst Count
  • BPMC 18
  • OLLI 14
  • Target Price
  • BPMC $125.88
  • OLLI $124.07
  • AVG Volume (30 Days)
  • BPMC 789.4K
  • OLLI 1.2M
  • Earning Date
  • BPMC 05-01-2025
  • OLLI 06-03-2025
  • Dividend Yield
  • BPMC N/A
  • OLLI N/A
  • EPS Growth
  • BPMC N/A
  • OLLI 10.62
  • EPS
  • BPMC N/A
  • OLLI 3.23
  • Revenue
  • BPMC $562,121,000.00
  • OLLI $2,271,705,000.00
  • Revenue This Year
  • BPMC $44.49
  • OLLI $15.77
  • Revenue Next Year
  • BPMC $33.04
  • OLLI $11.60
  • P/E Ratio
  • BPMC N/A
  • OLLI $34.50
  • Revenue Growth
  • BPMC 99.19
  • OLLI 8.04
  • 52 Week Low
  • BPMC $73.04
  • OLLI $78.81
  • 52 Week High
  • BPMC $121.90
  • OLLI $122.15
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 56.34
  • OLLI 48.42
  • Support Level
  • BPMC $94.38
  • OLLI $103.99
  • Resistance Level
  • BPMC $102.52
  • OLLI $116.32
  • Average True Range (ATR)
  • BPMC 3.77
  • OLLI 4.05
  • MACD
  • BPMC -0.38
  • OLLI -0.46
  • Stochastic Oscillator
  • BPMC 79.29
  • OLLI 41.08

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About OLLI Ollie's Bargain Outlet Holdings Inc.

Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.

Share on Social Networks: